Li Lin
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NAT10-mediated ac4C modifications regulate glioblastoma progression.
Journal: Cell death & disease
Published: December 14, 2024
LF-SynthSeg: Label-Free Brain Tissue-Assisted Tumor Synthesis and Segmentation.
Journal: IEEE journal of biomedical and health informatics
Published: October 31, 2024
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024
The peritumoral edema index and related mechanisms influence the prognosis of GBM patients.
Journal: Frontiers in oncology
Published: April 14, 2024
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 20, 2023
PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma.
Journal: Bioscience reports
Published: January 11, 2023
Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas.
Journal: Cancer medicine
Published: January 12, 2022
HSPA6 is Correlated With the Malignant Progression and Immune Microenvironment of Gliomas.
Journal: Frontiers in cell and developmental biology
Published: December 12, 2021
Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma.
Journal: Frontiers in oncology
Published: July 09, 2021
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Journal: Frontiers in oncology
Published: February 27, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026